Skip to main content

A PHASE III, OPEN-LABEL, MULTICENTER, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF GLOFITAMAB IN COMBINATION WITH GEMCITABINE

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Genentech, Inc.

Start Date

December 8, 2021

End Date

December 30, 2026
 

Administered By

Duke Cancer Institute

Awarded By

Genentech, Inc.

Start Date

December 8, 2021

End Date

December 30, 2026